The need for patients and their families to travel to and from clinical study sites, particularly those who live in remote places, has been a huge obstacle over the past 12 months. Some of these families require long-term stays in countries far from their own.
As our network of nurses continues to grow, we are facilitating more decentralised trials and carrying out an ever-increasing number of clinical trial visits to patients in their own homes.
Passionate about putting the patient at the heart of everything we do, LaQuinta shares what she has learnt through the challenges of the pandemic, what she thinks sets us apart from our competitors, and what exciting developments we can expect to see for the company in 2021.
Our CEO Tarquin Scadding-Hunt has more than 20 years’ experience in the pharma industry and has overseen many exciting developments in the business.
Passionate about making sure we do everything with compassion and kindness – inside and outside the business – Tarquin shares with us his vision for the company, what makes us different, and how he’s supporting us to create remarkable patient experiences.
The #NoGoingBack pledge is a statement from organisations across the world to continue forging forward. It’s a united front, and shows the importance of clinical leaders coming together to continue the momentum we’ve created in improving clinical trial conduct around the world.
The clinical trial landscape has changed dramatically since the outbreak of COVID-19. For the clinical research industry, these past few months have been anything but business as usual. However, it hasn’t meant clinical trials can’t continue, and many in the industry have been working together to find a ‘new normal’.
